ADOCIS
Adocis is a consultancy that offers financial performance improvement by tax optimization, employer contribution, and financing innovation.
ADOCIS
Industry:
Consulting Finance Financial Services
Founded:
1999-01-01
Address:
Angers, Pays De La Loire, France
Country:
France
Website Url:
http://www.adocis.com
Total Employee:
11+
Status:
Active
Contact:
+33-0241241025
Technology used in webpage:
Domain Not Resolving SPF Person Schema Microsoft Exchange Online Office 365 Mail Gravatar Profiles Microsoft Azure DNS
Similar Organizations
Studio Canovi
Studio Canovi is a business consultancy that offers services for finance, legal, company valuation, corporate restructuring and finance.
Studio Cavaliere
Studio Cavaliere is a consultancy that offers services for accounts, audit, labour consultancy, tax return and financial statements.
StudioSimoni
Studio Simoni is a consultancy that focuses on financial, tax, accounting, payroll, budget analysis, and personnel administration.
Šilhavý
Šilhavý is a consulting, analytical and development company focusing on information technology, economic consulting and financial planning.
Official Site Inspections
http://www.adocis.com
- Host name: www.ellipce.fr
- IP address: 83.167.47.93
- Location: Paris France
- Latitude: 48.8543
- Longitude: 2.3527
- Timezone: Europe/Paris
- Postal: 75011
More informations about "Adocis"
Adocia • Innovative medicine for everyone everywhere
Adocia primary focus lies in developing innovative formulations of insulins and other metabolic hormones. With the ambition of becoming a leading player in hormonal treatments, Adocia has established a diverse pipeline of specialty …See details»
Adocia - Crunchbase Company Profile & Funding
Organization. Adocia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Adocia operates as a …See details»
Adocia - healthtechinnovationdays6.com
Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The Company has …See details»
ADOCIA Company Overview, Contact Details & Competitors | LeadIQ
Oct 26, 2021 ADOCIA. Biotechnology Research LYON, France 51-200 Employees "Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical …See details»
Adocia 2021 Universal Registration Document PAGE 2
Adocia 2021 Universal Registration Document PAGE 7 Chapter 1 1 PRESENTATION OF ADOCIA AND ITS ACTIVITIES 8 1.1 About Adocia and its evolution 8 1.1.1. Legal …See details»
ADOCIA Overview | SignalHire Company Profile
ADOCIA is a public company that has been in the industry for 18 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. ... Organization …See details»
ADOCIA Reports Fourth Quarter 2024 Financial Results and …
Dec 31, 2024 Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of innovative …See details»
Top 21 Stellar Biotechnology Enterprises in France - Inven
Adocia is a biotechnology company specializing in protein delivery. They develop innovative technologies and drug formulations to enhance the efficacy and safety of protein-based therapies. ... ABL Biomanufacturing is a pure play Contract …See details»
ADOCIA - Lyonbiopôle
Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions. in the field of metabolic diseases, primarily diabetes and obesity. The company has …See details»
ADOCIA Grants Sanofi an Exclusive Right to Negotiate a …
ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing …See details»
Adocia SAS - Lyon, France - bionity.com
Oct 24, 2012 Adocia launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet Adocia SAS announced the launch of its second clinical trial for …See details»
Adocia SA (Adocia SA) - 药物管线_专利_临床试验_投融营收_最新 …
Adocia Anti-Obesity Candidate Fares Well vs Humalog In Phase II Study New data released Thursday from Adocia's Phase II trial of M1Pram in obese people with Type I Diabetes …See details»
Cagrilintide/semaglutide - Adocia - AdisInsight
Feb 12, 2025 If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with …See details»
Adocia - YouTube
Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The company has a …See details»
Eli Lilly and Adocia to co-develop ultra-rapid insulin
Dec 22, 2014 Lilly will reimburse Adocia for certain research and development expenses and the BioChaperone Lispro concentrated formulation is also part of the deal, according to Lilly. The …See details»
Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a …
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin treatment development deal has finished with mixed results for Adocia. Eli Lilly has now paid …See details»
Patents Assigned to Adocia - Justia Patents Search
Aug 17, 2021 Abstract: A composition in the form of an injectable aqueous solution, the pH of which is from 3.0 to 4.4, including at least a rapid-acting insulin analog and at least one …See details»
Number of Shares and Voting Rights of ADOCIA as of February …
Number of Shares and Voting Rights of ADOCIA as of February 28th, 2025. Previous article ADOCIA Reports Fourth Quarter 2024 Financial Results and Provides a Business Update. …See details»
Adocia SA (LON: 0QAI) Statistics & Valuation Metrics - Stock Analysis
Jan 23, 2025 Detailed statistics for Adocia SA (LON: 0QAI) stock, including valuation metrics, financial numbers, share information and more.See details»
ADOCIA annonce le premier sujet traité dans les essais cliniques ...
Adocia est une société cotée sur le marché Euronext. TM. Paris (Euronext : ADOC ; ISIN : FR0011184241). Pour plus d’information, contactez . Adocia . Gérard Soula . CEO . …See details»